Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
An open randomized trial showed that for a first episode of schizophrenia, four second-generation antipsychotics were no more effective than haloperidol, but they did have lower discontinuation rates.…
The investigational antiplatelet agent Prasugrel improves ischemic event rates after percutaneous coronary intervention, whatever type of stent is used, researchers reported at the American College of Cardiology meeting.…
New data stemming from the PERISCOPE trial show intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, Actos reduced the atherosclerotic burden in the…
According to the FDA, mortality was substantially higher in patients who had an AneuRx Stent Graft implanted to prevent abdominal aortic aneurysm rupture than in patients who had…
The FDA has posted a warning alerting clinicians of pooled data from 29 placebo-controlled trials of tiotropium that revealed excess strokes among COPD patients on active treatment. References…
New research shows variants in nine genes involved with lipid synthesis and metabolism predicted risk of cardiovascular disease, independently of blood lipid levels. References and Resources Kathiresan S,…
A new study shows that the aromatase inhibitor letrozole can prevent late recurrence of breast cancer. References and Resources Goss P, et al. Late extended adjuvant treatment with…
Statin use at the time of ovarian cancer surgery was associated with a 50% increase in the duration of progression-free survival and with more than a year of…
The Oncologic Drug Advisory Committee said the FDA should mandate a restricted distribution system for cancer patients given erythropoiesis-stimulating agents. References and Resources FDA.gov Sponsored by The Doctor’s…
A meta analysis of more than 2,500 patients from nine trials showed that antibiotics for those who suffer from rhinosinusitis is unnecessary. References and Resources Young J, et…
